BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33911468)

  • 1. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections.
    Malik SA; Zhu C; Li J; LaComb JF; Denoya PI; Kravets I; Miller JD; Yang J; Kramer M; McCombie WR; Robertson CE; Frank DN; Li E
    World J Gastroenterol; 2021 Apr; 27(14):1465-1482. PubMed ID: 33911468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer.
    Kono Y; Inoue R; Teratani T; Tojo M; Kumagai Y; Morishima S; Koinuma K; Lefor AK; Kitayama J; Sata N; Horie H
    Digestion; 2022; 103(2):141-149. PubMed ID: 34619680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
    Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
    World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    Shah MS; DeSantis T; Yamal JM; Weir T; Ryan EP; Cope JL; Hollister EB
    PLoS One; 2018; 13(11):e0207002. PubMed ID: 30412600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing.
    Suga D; Mizutani H; Fukui S; Kobayashi M; Shimada Y; Nakazawa Y; Nishiura Y; Kawasaki Y; Moritani I; Yamanaka Y; Inoue H; Ojima E; Mohri Y; Nakagawa H; Dohi K; Takaba K; Wada H; Shiraki K
    BMC Gastroenterol; 2022 Jun; 22(1):313. PubMed ID: 35752764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut mucosal microbiota profiles linked to colorectal cancer recurrence.
    Huo RX; Wang YJ; Hou SB; Wang W; Zhang CZ; Wan XH
    World J Gastroenterol; 2022 May; 28(18):1946-1964. PubMed ID: 35664963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
    Tesolato S; Ortega-Hernández A; Gómez-Garre D; Claver P; De Juan C; De la Serna S; Paz M; Domínguez-Serrano I; Dziakova J; Rivera D; Torres A; Iniesta P
    PLoS One; 2023; 18(10):e0292551. PubMed ID: 37796924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota Profile and Impact of
    de Carvalho AC; de Mattos Pereira L; Datorre JG; Dos Santos W; Berardinelli GN; Matsushita MM; Oliveira MA; Durães RO; Guimarães DP; Reis RM
    Front Oncol; 2019; 9():813. PubMed ID: 31555583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
    Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
    Taylor WS; Pearson J; Miller A; Schmeier S; Frizelle FA; Purcell RV
    PLoS One; 2020; 15(5):e0233170. PubMed ID: 32433701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Comparison of Fecal Microbiota in Left-Side and Right-Side Human Colorectal Cancer.
    Miyake T; Mori H; Yasukawa D; Hexun Z; Maehira H; Ueki T; Kojima M; Kaida S; Iida H; Shimizu T; Ohno M; Andoh A; Tani M
    Eur Surg Res; 2021; 62(4):248-254. PubMed ID: 34198297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
    Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
    Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct intratumoral microbiome of young-onset and average-onset colorectal cancer.
    Barot SV; Sangwan N; Nair KG; Schmit SL; Xiang S; Kamath S; Liska D; Khorana AA
    EBioMedicine; 2024 Feb; 100():104980. PubMed ID: 38306898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer.
    Yuan D; Tao Y; Wang H; Wang J; Cao Y; Cao W; Pan S; Yu Z
    Invest New Drugs; 2022 Oct; 40(5):884-894. PubMed ID: 35727391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
    Allali I; Delgado S; Marron PI; Astudillo A; Yeh JJ; Ghazal H; Amzazi S; Keku T; Azcarate-Peril MA
    Gut Microbes; 2015; 6(3):161-72. PubMed ID: 25875428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.